Yahoo Web Search

Search results

  1. Sep 14, 2021 · PITTSBURGH, Sept. 14, 2021 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology platform company Drugging the Genome™ to address disease at...

    • Neubase Therapeutics, Inc.
  2. Sep 14, 2021 · At NeuBase, Dr. Rossomando will be responsible for manufacturing and process development, analytical development, and biophysical characterization in support of FDA regulatory submissions. Prior to joining NeuBase, Dr. Rossomando was Chief Process Development Officer at Pinetree Therapeutics, where he oversaw early-stage upstream and downstream ...

  3. Oct 5, 2021 · After deducting $1.3 billion of his assets that have been frozen, Forbes estimates his net worth at $4.7 billion.

  4. Anthony Rossomando (born February 21, 1976) is an American musician. Rossomando, along with Carl Barât, was a founding member of Dirty Pretty Things. [1] He previously stood in for Pete Doherty in The Libertines as a touring member. He has also been a live member of British New Rave band Klaxons.

  5. Jan 10, 2024 · Anthony Rossomando is one of the richest Guitarist from United States. According to our analysis, Wikipedia, Forbes & Business Insider, Anthony Rossomando 's net worth $5 Million. (Last Update: December 11, 2023)

  6. View Anthony Rossomandos profile on LinkedIn, a professional community of 1 billion members. With over 25 years of work experience in the biotech industry, I have developed expertise…

    • Meltemi Biopharma
  7. People also ask

  8. Feb 8, 2019 · About a decade ago, Anthony Rossomando, founder of the now-defunct Boston-based band The Damn Personals, was living in London and working as a musician when he met Grammy-winning producer Mark...

  1. People also search for